Savage M Tessa, Ferro Charles J, Pinder Sarah J, Tomson Charles R V
Department of Renal Medicine, The Richard Bright Renal Unit, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
Clin Sci (Lond). 2002 Jul;103(1):59-65. doi: 10.1042/cs1030059.
Arterial stiffness potently predicts mortality in dialysis patients. Pulse-wave analysis permits the non-invasive assessment of indices of arterial stiffness and the central pressure waveform by applanation tonometry. The aim of this study was to assess the reproducibility of pulse-wave analysis in patients with chronic renal failure. A total of 188 subjects (23 healthy controls, along with 71 pre-dialysis, 67 dialysis and 27 transplant patients) took part. Duplicate measurements were recorded of brachial blood pressure using the semi-automated Omron 705 device and of the radial artery pressure waveform using applanation tonometry. The central pressure aortic waveform was then obtained by application of a transfer function incorporated into the SphygmoCor software. Central aortic mean blood pressure (MBP), indices of arterial stiffness [augmentation index (AIx) and time to reflection (TR)] and the subendocardial viability ratio (SEVR) were analysed for intra-observer, inter-observer and long-term reproducibility using Bland-Altman plots. The mean (+/-S.D.) intra-observer difference was 0+/-4% for AIx, 0+/-20 ms for TR, 0+/-3 mmHg for aortic MBP and 0+/-18% for the SEVR. Inter-observer mean differences were 0+/-3% for AIx, 1+/-7 ms for TR, 1+/-4 mmHg for aortic MBP and 1+/-9% for the SEVR. For the long-term study, the mean differences were -1+/-9% for AIx, -2+/-13 mmHg for aortic MBP, -2+/-12 ms for TR and 1+/-29% for the SEVR. Pulse-wave analysis showed excellent reproducibility in all the studies, and is therefore suitable for use in all patients with chronic renal failure. Further prospective and interventional studies are now required to assess whether AIx and TR are important prognostic indices of cardiovascular events, and therefore relevant surrogate indices of arterial stiffness in this susceptible population.
动脉僵硬度可有效预测透析患者的死亡率。脉搏波分析可通过压平式眼压计对动脉僵硬度指标和中心压力波形进行无创评估。本研究的目的是评估慢性肾衰竭患者脉搏波分析的可重复性。共有188名受试者参与,包括23名健康对照者,以及71名透析前患者、67名透析患者和27名移植患者。使用半自动欧姆龙705设备记录肱动脉血压的重复测量值,并使用压平式眼压计记录桡动脉压力波形。然后通过应用SphygmoCor软件中包含的传递函数获得中心压力主动脉波形。使用Bland-Altman图分析中心主动脉平均血压(MBP)、动脉僵硬度指标[增强指数(AIx)和反射时间(TR)]以及心内膜下存活比率(SEVR)的观察者内、观察者间和长期可重复性。AIx的观察者内平均差异为0±4%,TR为0±20毫秒,主动脉MBP为0±3毫米汞柱,SEVR为0±18%。观察者间平均差异为AIx 0±3%,TR 1±7毫秒,主动脉MBP 1±4毫米汞柱,SEVR 1±9%。对于长期研究,AIx的平均差异为-1±9%,主动脉MBP为-2±13毫米汞柱,TR为-2±12毫秒,SEVR为1±29%。脉搏波分析在所有研究中均显示出出色的可重复性,因此适用于所有慢性肾衰竭患者。现在需要进一步的前瞻性和干预性研究,以评估AIx和TR是否是心血管事件的重要预后指标,因此是否是该易感人群中动脉僵硬度的相关替代指标。